We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AACC's Go-To Conclave for Networking, Research, Technology

By CLN Stat
Posted on 29 Jul 2019
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo offers something for everyone in clinical laboratory medicine, showcasing the latest in precision medicine, novel biomarker research, the opioid epidemic and journals hot topics, plus a host of networking events and technology game-changers at the Expo.

Janetta Bryksin, PhD, DABCC, co-director of clinical chemistry and director of special chemistry at Emory Healthcare in Atlanta, is among the many enthusiastic AACC members who plan to attend this year’s meeting in Anaheim, California. More...
“If there is one conference to go to each year, it’ll be the AACC Annual Scientific Meeting for me,” Bryksin told CLN Stat. “It offers many learning and networking opportunities through scientific sessions, Expo presenters, and local section and division meetings, as well as informal mixer meetings.”

Joshua Akin, clinical laboratory scientist at UC San Diego Health System Center for Advanced Laboratory Medicine, is another AACC member gearing up for the ASM. “It’s a great opportunity to brush up on recent research and new technology, as well as current trends and emerging issues in clinical labs,” Akin said.

Bryksin and Akin neatly sum up the top five reasons for attending this yearly conclave:
  • 5 Plenary Sessions: Clinical genomics, biomarker discoveries, and extreme molecular diagnostics are among the cutting-edge topics being presented by world-class researchers. Another fascinating session will explore translating gene-disease associations to brain circuitry.

  • 4(0)+ Special Events and Socials: Participants have 40 events to choose from, including education on shared interest topics and mixers hosted by AACC groups and divisions. For the last few years, the Society for Young Clinical Laboratorians (SYCL) workshops have been the highlight of Bryksin’s Annual Scientific Meeting experience. “SYCL workshops are always very engaging, educational, and fun! I’m looking forward to learning about the impact of technology utilization in laboratory medicine at the SYCL workshop this year,” she said.

    Workshops and networking events create long-lasting memories for attendees. Akin fondly recalls a local AACC section networking event at the 2018 Annual Scientific Meeting in San Diego. Participants met at Petco Park and “ate hot dogs, caught up with old colleagues, and watched the San Diego Padres beat the Pittsburgh Pirates,” he recalled.

  • 3 Days of the Clinical Lab Expo: There’s no better resource for cutting-edge laboratory technology than the Clinical Lab Expo. With more than 850 exhibiting companies and 200 new product introductions, this event rightly claims the title as the world’s largest exposition for clinical laboratory products and services. Visiting the Expo for the first time, “it was so vastly, overwhelmingly huge with thousands of people all discussing the latest technologies, I didn’t know where to start!” said Alec Saitman, PhD, DABCC (CC, TC), director of toxicology and special chemistry at Providence Regional Laboratories in Portland, Oregon. Saitman not only will be attending this year’s Annual Scientific Meeting but also actively participating, as a SYCL workshop instructor and as a member of the CLN Daily editorial board, covering the meeting for the event’s official publication.

  • 2(0,000) Lab Medicine Attendees: There’s no better place for a clinical lab professional to make connections with more than 20,000 expected for this year’s meeting. “I always enjoy chatting with vendors and laboratory professionals from all different walks of laboratory medicine,” said Akin.

  • 1 Disruptive Tech Award Winner: AACC’s Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. Developers of precision and personalized medicine diagnostics headline this year’s award. Three finalist teams will present data on their technologies and one team will walk away with a cash prize.


The 71st AACC Annual Scientific Meeting & Clinical Lab Expo takes place on August 4–8 in Anaheim, California. AACC members receive a discount on registration. Come join the conclave in sunny Southern California to network and learn about the latest breakthroughs in laboratory scientists from world-renowned speakers.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.